# US 2012/0252129 A1 · Pre-concentrator and method of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252129 A1
- Document ID: US20120252129A1
- Status: Published application
- Kind: A1
- Application number: 13/431,054
- Filed: 2012-03-27
- Published: 2012-10-04
- Earliest claimed: 2011-03-28
- Assignees: University of Louisville Research Foundation, Inc.
- Inventors: Xiaoan Fu; Richard Higashi; Michael Nantz
- Web page: https://patentgrep.com/patent/US20120252129A1

## CPC

- G01N 33/497: of gaseous biological material, e.g. breath
- B01J 20/3204: {Inorganic carriers, supports or substrates}
- B01J 20/3251: {comprising at least two different types of heteroatoms selected from nitrogen, oxygen or sulphur}
- G01N 1/2202: {involving separation of sample components during sampling}
- G01N 1/40: Concentrating samples
- G01N 1/405: {by adsorption or absorption}
- G01N 30/08: using an enricher
- G01N 30/6095: {Micromachined or nanomachined, e.g. micro- or nanosize}
- G01N 30/72: Mass spectrometers {(mass spectrometers per se H01J49/00)}
- G01N 2030/085: {using absorbing precolumn}
- Y10T 436/200833: Carbonyl, ether, aldehyde or ketone containing
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- Y10T 436/255: including use of a solid sorbent, semipermeable membrane, or liquid extraction
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A chemical pre-concentrator is provided having a support structure, an airflow conduit, and a layer of a reactive chemical compound on a surface of the support structure is used for collecting and pre-concentrating at least one chemical analyte from a dilute sample. A method of concentrating a gaseous sample is provide that includes exposing the chemical pre-concentrator with a dilute gaseous sample that contains at least one chemical analyte; and forming a conjugate of the at least one chemical analyte. A method of diagnosing a disease state in a mammalian patient is provided using the chemical pre-concentrator.

## Claims

### Claim 1

A chemical pre-concentrator for collecting and pre-concentrating at least one chemical analyte from a dilute gaseous sample, the chemical pre-concentrator comprising:
a support structure having a surface;
an airflow conduit directed at the surface of the support structure; and
a layer on the surface of the support structure, the layer comprising a reactive chemical compound having a general formula (I) of
H2N—Z-L-Y (I)
wherein Z is NH, NR or O; L is a linking group; Y is a di-substituted or tri substituted N or P moiety; R is selected from the group consisting of alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms, wherein the reactive chemical compound is capable of forming a conjugate with the at least one chemical analyte to thereby retain the at least one chemical analyte with the chemical pre-concentrator.

### Claim 2 (depends on 1)

The chemical pre-concentrator of claim 1, wherein the surface of the support structure comprises a material selected from the group consisting of dielectrics and semiconductors.

### Claim 3 (depends on 1)

The chemical pre-concentrator of claim 1, wherein the support structure comprises a material selected from the group consisting of silicon, polycrystalline silicon, silicon oxide, silicon nitride, silicon oxynitride, silicon carbide, titanium, titanium oxide, titanium nitride, titanium oxynitride, titanium carbide, aluminum, aluminum oxide, aluminum nitride, aluminum oxynitride, and aluminum carbide.

### Claim 4 (depends on 1)

The chemical pre-concentrator of claim 1, wherein at least the surface of the support structure comprises silicon oxide, titanium oxide, aluminum oxide, or combinations thereof.

### Claim 5 (depends on 1)

The chemical pre-concentrator of claim 1, wherein the surface of the support structure is configured with microchannels, micropillars, pores, or combinations thereof.

### Claim 6 (depends on 1)

The chemical pre-concentrator of claim 1, further comprising a housing surrounding said support structure, wherein said housing having an inlet and an outlet, wherein at least one of the outlet or the inlet is configured to couple with a sampling pump to thereby facilitate the transfer of a portion of the dilute gaseous sample outside of the housing into the housing through the inlet.

### Claim 7 (depends on 1)

The chemical pre-concentrator of claim 1, wherein Z is O, and Y is a di-substituted or tri-substituted nitrogen to provide the reactive chemical compound having a general formula (II)
wherein R1 and R2 are independently selected from the group consisting of alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms, or wherein R1 and R2 in combination form a heterocyclic ring; R3 is selected from the group consisting of H, alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms; and A is an anionic counter-ion; and wherein said linking group L comprises a non-ionic segment selected from the group consisting of a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl, and an ether.

### Claim 8 (depends on 7)

The chemical pre-concentrator of claim 7, wherein R1, R2 and R3 are alkyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms.

### Claim 9 (depends on 7)

The chemical pre-concentrator of claim 7, wherein at least one of R1, R2 and R3 is a methyl group and A is a halide.

### Claim 10 (depends on 7)

The chemical pre-concentrator of claim 7, wherein at least one of R1, R2 and R3 is a substituted or unsubstituted alkyl including at least two heteroatoms, and having a general formula of -L1-Z—NH2, wherein L1 is a linking group between an ammonium nitrogen and Z.

### Claim 11 (depends on 1)

The chemical pre-concentrator of claim 1, wherein Z is O, and Y is a di-substituted nitrogen to provide the reactive chemical compound having a general formula (III)
wherein R1 and R2 are independently selected from the group consisting of alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms, or wherein R1 and R2 in combination form a heterocyclic ring.

### Claim 12 (depends on 1)

The chemical pre-concentrator of claim 1, wherein the at least one chemical analyte comprises an aldehyde or ketone functional group.

### Claim 13

A method of concentrating at least one chemical analyte in a gaseous sample, comprising:
contacting the gaseous sample and a chemical pre-concentrator, wherein the chemical pre-concentrator comprises
a reactive chemical compound having a general formula (I) of
H2N—Z-L-Y (I)
wherein Z is NH, NR or O; L is a linking group; Y is a di-substituted or a tri-substituted N or P moiety; R is selected from the group consisting of alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms; and A is an anionic counter-ion; and
forming a conjugate of the reactive chemical compound and the at least one chemical analyte to retain the at least one chemical analyte with the chemical pre-concentrator.

### Claim 14 (depends on 13)

The method of claim 13, wherein the chemical pre-concentrator further comprises a support structure having a surface,
an airflow conduit directed at the surface of the support structure; and
a layer on the surface of the support structure, the layer comprising the reactive chemical compound, the method further comprising:
contacting the layer on the surface with a solvent to dissolve at least a portion of the conjugate to form a concentrated sample of the conjugate.

### Claim 15 (depends on 14)

The method of claim 14, further comprising analyzing at least a portion of the concentrated sample to identify or quantify the conjugate.

### Claim 16 (depends on 13)

The method of claim 13, wherein the at least one chemical analyte comprises an aldehyde or ketone functional group.

### Claim 17 (depends on 15)

The method of claim 15, wherein the analyzing at least a portion of the concentrated sample does not use chromatography.

### Claim 18 (depends on 15)

The method of claim 15, wherein the analyzing at least a portion of the concentrated sample includes using a mass spectrometer.

### Claim 19 (depends on 18)

The method of claim 18, wherein the mass spectrometer uses Fourier-transform ion cyclotron resonance mass spectrometry (FTICR-MS).

### Claim 20 (depends on 15)

The method claim 15 further comprising
obtaining a gas sample containing the at least one chemical analyte, wherein the at least one chemical analyte is a biomarker relating to the presence of a disease; and
diagnosing the presence of and/or absence of the disease by the identifying or the quantifying of the biomarker performed in the analyzing step.

### Claim 21 (depends on 20)

The method of claim 20, wherein the biomarker comprises a portion of an isotopically labeled metabolite.

### Claim 22

A method of diagnosing a disease state in a mammalian patient comprising:
obtaining a biological sample containing at least one chemical analyte from the mammalian patient, wherein the at least one chemical analyte is a biomarker relating to the presence of a disease;
contacting a chemical pre-concentrator with a gaseous sample containing at least a portion of the biological sample, wherein the chemical pre-concentrator comprises
a reactive chemical compound having a general formula of
H2N—Z-L-Y
wherein Z is NH, NR or O; L is a linking group; Y is a di-substituted or tri-substituted N or P moiety; R is selected from the group consisting of alkyls, aralkyls, aralkenyls, and aralkynyls, each of which may be substituted or unsubstituted, and optionally contain one or more heteroatoms;
forming a conjugate of the reactive chemical compound and the biomarker to retain the biomarker with the chemical pre-concentrator; and
performing analysis of the conjugate to identify and/or quantify the biomarker.

### Claim 23 (depends on 22)

The method of claim 22, wherein the pre-concentrator further comprises a support structure having a surface,
an airflow conduit directed at the surface of the support structure; and
a layer on the surface of the support structure, the layer comprising the reactive chemical compound, the method further comprising:
contacting the layer on the surface with a solvent to dissolve at least a portion of the conjugate to form a concentrated sample of the conjugate.

### Claim 24 (depends on 23)

The method of claim 23, further comprising
analyzing at least a portion of the concentrated sample to establish the identity or quantity of the conjugate and/or the biomarker; and
diagnosing the presence of and/or absence of the disease based on the identity or the quantity of the biomarker.

### Claim 25 (depends on 24)

The method of claim 24 wherein the analyzing at least a portion of the concentrated sample includes using a mass spectrometer.

### Claim 26 (depends on 25)

The method of claim 25, wherein the mass spectrometer uses Fourier-transform ion cyclotron resonance mass spectrometry (FTICR-MS).
